CSF1R and neoplasm: In most studies, anti‐CSF1R antibody‐based therapies were shown to decrease total macrophages population in various tumor models in mice and patients (Manthey et al, 2009; Patel & Player, 2009; Ries et al, 2014; Cotechini et al, 2015).